CYTOMX THERAPEUTICS INC. - COMMON STOCK

CytomX Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

05 янв 2022 05:00:03 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Announces Preliminary Results for Ongoing Phase 2 Expansion Study of CX-2029, a First-in-Class Antibody-Drug Conjugate Candidate Targeting the Transferrin Receptor, CD71

20 дек 2021 13:05:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Present at Upcoming November Investor Conferences

11 ноя 2021 05:00:01 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update

04 ноя 2021 13:15:01 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Present Preclinical Data for Conditionally Activated Cytokine Platform at Society for Immunotherapy of Cancer Annual Meeting

01 ноя 2021 05:00:01 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Announce Third Quarter 2021 Financial Results on November 4, 2021

28 окт 2021 05:00:03 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Announces New Employment Inducement Grants

18 окт 2021 05:00:01 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Appoints Dr. Alan Ashworth to Board of Directors

04 окт 2021 05:00:01 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Announces New Employment Inducement Grants

16 сен 2021 05:00:02 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference

07 сен 2021 05:00:02 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Announces New Employment Inducement Grants

17 авг 2021 05:00:01 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Announces Second Quarter 2021 Financial Results and Provides Business Update

05 авг 2021 13:15:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Announces Multiple Publications on Pacmilimab (CX-072), a Conditionally Activated Inhibitor of Programmed Death-Ligand 1 (PD-L1)

04 авг 2021 05:00:02 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Present at Upcoming August Investor Conferences

02 авг 2021 05:00:01 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021

29 июл 2021 05:00:01 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Announces Publication of First-in-Human Data for CX-2029 in Clinical Cancer Research

21 июн 2021 05:00:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Present at Jefferies Virtual Healthcare Conference

27 май 2021 05:00:01 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Announces First Quarter 2021 Financial Results and Provides Business Update

06 май 2021 13:15:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Announce First Quarter 2021 Financial Results on May 6, 2021

29 апр 2021 05:00:01 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Announces New Employment Inducement Grants

14 апр 2021 13:01:00 Источник Nasdaq GlobeNewswire